FAP and ovarian endometrial cancer: Remarkably, exemplary immunohistochemistry of a patient with high-grade endometrial ovarian cancer demonstrated moderate FAP expression in the stroma, markedly strong FAP expression within neoplastic cells, and scarcely none in presumably healthy non-tumorous cells, enabling a clear distinction between malignant and healthy tissue (Fig. 9).